# Treatment of Idiopathic Pulmonary Fibrosis With Long Acting Octreotide

> **NCT00463983** · PHASE1,PHASE2 · COMPLETED · sponsor: **Institut National de la Santé Et de la Recherche Médicale, France** · enrollment: 25 (actual)

## Conditions studied

- Idiopathic Pulmonary Fibrosis

## Interventions

- **DRUG:** octreotide

## Key facts

- **NCT ID:** NCT00463983
- **Lead sponsor:** Institut National de la Santé Et de la Recherche Médicale, France
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2010-01
- **Final completion:** 2012-01
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2025-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00463983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00463983, "Treatment of Idiopathic Pulmonary Fibrosis With Long Acting Octreotide". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00463983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*